Fondaparinux: a new synthetic pentasaccharide for thrombosis prevention
- 1 May 2002
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 359 (9319), 1710-1711
- https://doi.org/10.1016/s0140-6736(02)08660-9
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture SurgeryNew England Journal of Medicine, 2001
- Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee SurgeryNew England Journal of Medicine, 2001
- A Synthetic Pentasaccharide for the Prevention of Deep-Vein Thrombosis after Total Hip ReplacementNew England Journal of Medicine, 2001
- Extended Thromboprophylaxis with Low Molecular Weight Heparin Reduces Symptomatic Venous Thromboembolism following Lower Limb Arthroplasty - a Meta-analysisThrombosis and Haemostasis, 2001
- Prevention of Venous ThromboembolismChest, 2001
- SR 90107A/Org 31540, a Novel Anti‐Factor Xa Antithrombotic AgentCardiovascular Drug Reviews, 1997